Back to top
more

Inspire Medical Systems (INSP)

(Delayed Data from NYSE)

$87.91 USD

87.91
10,968,618

-42.04 (-32.35%)

Updated Aug 5, 2025 04:00 PM ET

After-Market: $86.99 -0.92 (-1.05%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value A Growth C Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 29% (71 out of 246)

Industry: Medical Info Systems

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Inspire Medical Systems (INSP) Surpasses Q4 Earnings and Revenue Estimates

by Zacks Equity Research

Inspire (INSP) delivered earnings and revenue surprises of 1,325% and 0.05%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Inspire Medical Systems (INSP) Expected to Beat Earnings Estimates: Should You Buy?

by Zacks Equity Research

Inspire (INSP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Inspire Medical (INSP) Reports Solid Preliminary Q4 Revenues

by Zacks Equity Research

Inspire Medical's (INSP) revenue growth in the fourth quarter is likely to have been boosted by improved operating leverage.

Zacks Equity Research

3 Reasons to Hold Inspire Medical (INSP) Stock in Your Portfolio

by Zacks Equity Research

Inspire Medical's (INSP) focus on R&D raises optimism about the stock.

Zacks Equity Research

Inspire (INSP) Up 16.8% Since Last Earnings Report: Can It Continue?

by Zacks Equity Research

Inspire (INSP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

3 Reasons to Retain Inspire Medical (INSP) Stock for Now

by Zacks Equity Research

Inspire Medical's (INSP) focus on R&D raises optimism about the stock.

Zacks Equity Research

Inspire Medical (INSP) Q3 Earnings Top Estimates, Revenues Lag

by Zacks Equity Research

Inspire Medical's (INSP) both geographic regions witness strong revenue growth in the third quarter.

Zacks Equity Research

Charles River (CRL) to Report Q3 Earnings: What's in Store?

by Zacks Equity Research

Charles River's (CRL) CRADLE initiative and research models in North America and China are anticipated to have maintained their growth momentum in the third quarter.

Zacks Equity Research

Inspire Medical Systems (INSP) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

by Zacks Equity Research

Inspire (INSP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Penumbra (PEN) to Report Q3 Earnings: What's in the Cards?

by Zacks Equity Research

Penumbra (PEN) will likely report strong Neuro sales growth on the strength of its RED 72 (with the proprietary SENDit technology), RED 43 and BMX81.

Zacks Equity Research

What's in Store for Boston Scientific (BSX) in Q3 Earnings?

by Zacks Equity Research

With global staffing issues and the supply situation gradually improving, Boston Scientific's (BSX) international business is expected to have improved further in the third quarter.

Zacks Equity Research

What's in Store for Edwards Lifesciences (EW) in Q3 Earnings?

by Zacks Equity Research

Outside the United States, Edwards Lifesciences (EW) TAVR sales growth will likely be driven by broad-based adoption of the SAPIEN platform.

Zacks Equity Research

Here's Why You Should Retain Inspire Medical (INSP) Stock Now

by Zacks Equity Research

Inspire Medical's (INSP) focus on R&D raises optimism about the stock.

Zacks Equity Research

Should Vanguard Russell 2000 ETF (VTWO) Be on Your Investing Radar?

by Zacks Equity Research

Style Box ETF report for VTWO

Zacks Equity Research

Should Vanguard Russell 2000 Growth ETF (VTWG) Be on Your Investing Radar?

by Zacks Equity Research

Style Box ETF report for VTWG

Zacks Equity Research

Inspire Medical (INSP) Q2 Earnings & Revenues Top Estimates

by Zacks Equity Research

Inspire Medical's (INSP) both geographic regions witness strong revenue growth in the second quarter.

Zacks Equity Research

Compared to Estimates, Inspire (INSP) Q2 Earnings: A Look at Key Metrics

by Zacks Equity Research

While the top- and bottom-line numbers for Inspire (INSP) give a sense of how the business performed in the quarter ended June 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks Equity Research

Inspire Medical Systems (INSP) Reports Q2 Loss, Tops Revenue Estimates

by Zacks Equity Research

Inspire (INSP) delivered earnings and revenue surprises of 19.61% and 9.76%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Debanjana Dey headshot

MedTech Stocks to Watch for Earnings on Aug 1: ECL, NVRO, INSP

by Debanjana Dey

MedTech companies' Q2 results are likely to reflect strength in customer demand. Let's see how ECL, NVRO and INSP are placed ahead of their earnings releases.

Zacks Equity Research

Should Vanguard Russell 2000 ETF (VTWO) Be on Your Investing Radar?

by Zacks Equity Research

Style Box ETF report for VTWO

Zacks Equity Research

Inspire Medical (INSP) Hits 52-Week High: What's Aiding It?

by Zacks Equity Research

Investors are optimistic about Inspire Medical's (INSP) global presence.

Zacks Equity Research

Inspire (INSP) Gets FDA Nod for Expanded Indication of AHI

by Zacks Equity Research

The FDA approves Inspire's (INSP) application to expand the indication to include patients with AHI up to 100 events per hour.

Zacks Equity Research

Syneos Health (SYNH) Down 0.1% Since Last Earnings Report: Can It Rebound?

by Zacks Equity Research

Syneos Health (SYNH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

Why Is Inspire (INSP) Up 6.3% Since Last Earnings Report?

by Zacks Equity Research

Inspire (INSP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

3 Reasons to Hold Inspire Medical (INSP) Stock in Your Portfolio

by Zacks Equity Research

Investors continue to be optimistic about Inspire Medical (INSP) on the back of its product innovations.